Description: The purpose of this American Gastroenterological Association (AGA) Clinical Practice Update is to facilitate understanding and improve clinical management of patients with hepatitis delta virus infection.
Methods: This commentary was commissioned and approved by the AGA Institute Clinical Practice Updates Committee and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership, and underwent internal peer review by the Clinical Practice Updates Committee and external peer review through standard procedures of Gastroenterology.
Keywords: Antivirals; Bulevirtide; Cirrhosis; Hepatitis Delta.
Copyright © 2025 AGA Institute. Published by Elsevier Inc. All rights reserved.